1Chalmers J. The 1999 WHO-ISH Guidelines for the Management of Hypertension. Med J Aust, 1999,171:458-459.
2Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation, 1999,100:354-360.
3Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA, 2005,294:466-472.
4Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee Prevention, Detection,Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003,42 : 1206-1252.
5Kario K, Shimada K. Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure. Clin Exp Hypertens, 2004,26:177-189.
6Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension, 2004,44 : 398 -404.
7Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA,2005 ,294 :466-472.
8Wassertheil-Smoller S, Anderson G, Psaty BM, et al. Hypertension and its treatment in postmenopausal women : baseline data from the Women's Health Initiative. Hypertension, 2000,36 : 780-789.
9Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet, 1998,351:1755-1762.
10ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TriM. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA,2002 ,288:2981-2997.
